In patients with gestational diabetes, FGF-23 may be a promising indicator of subclinical arteriosclerosis [36], and FGF-23 has previously been shown to be positively correlated with the development of coronary atherosclerosis [37]. The gene discussed is FGF23; the disease is coronary atherosclerosis.